Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

Rick A Vreman, Joost W Geenen, Anke M Hövels, Wim G Goettsch, Hubert G M Leufkens, Maiwenn J Al

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science